Products

(S)-tetrahydrofuran-3-ol, also known as THF-3-ol, is a chemical compound that has been identified as a synthetic intermediate used in the production of two different drugs: Empagliflozin and Afatinib.Empagliflozin is an oral medication belonging to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is primarily used in the management of type 2 diabetes mellitus. Empagliflozin works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and lowering blood sugar levels. (S)-tetrahydrofuran-3-ol is used as a key intermediate in the synthesis of Empagliflozin, playing a crucial role in the process of forming its chemical structure.Afatinib, on the other hand, is an oral medication classified as a tyrosine kinase inhibitor. It is used for the treatment of certain types of lung cancer, specifically non-small cell lung cancer (NSCLC) with specific mutations, as well as metastatic tomes or recurrent NSCLC. Afatinib works by blocking the activity of tyrosine kinase enzymes in cancer cells, thereby inhibiting cell growth and division. (S)-tetrahydrofuran-3-ol is involved in the synthesis of Afatinib, serving as an important building block in the production of the drug.Both Empagliflozin and Afatinib are essential medications that provide therapeutic benefits in their respective treatment areas. The use of (S)-tetrahydrofuran-3-ol as an intermediate reflects its importance in the synthesis process of these drugs, as it contributes to the formation of the final chemical structure necessary for their pharmacological activity.It is worth noting that (S)-tetrahydrofuran-3-ol itself is not used directly as a medication, but rather as a part of the chemical synthesis process for the production of Empagliflozin and Afatinib. Its role in this context is critical in ensuring the manufacturing and availability of these medications to patients who benefit from their therapeutic effects.In conclusion, (S)-tetrahydrofuran-3-ol is an essential intermediate compound utilized in the synthesis of two significant medications, Empagliflozin and Afatinib. Its involvement in the production process contributes to the formation of the final chemical structures necessary for the therapeutic activity of these drugs in the treatment of type 2 diabetes and non-small cell lung cancer.